Lentzsch S - Search Results

1

Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis.

Hopson MB, Bhutani D, Sarkaria S, Maurer MS, Griffin JM, Mapara M, Lentzsch S, Chakraborty R. Hopson MB, et al. Among authors: lentzsch s. Leuk Lymphoma. 2022 Sep;63(9):2109-2113. doi: 10.1080/10428194.2022.2060502. Epub 2022 Apr 23. Leuk Lymphoma. 2022. PMID: 35465769

2

SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth.

Feng R, Anderson G, Xiao G, Elliott G, Leoni L, Mapara MY, Roodman GD, Lentzsch S. Feng R, et al. Among authors: lentzsch s. Blood. 2007 Mar 1;109(5):2130-8. doi: 10.1182/blood-2006-07-027458. Epub 2006 Nov 9. Blood. 2007. PMID: 17095620 Free article.

3

The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.

Feng R, Oton A, Mapara MY, Anderson G, Belani C, Lentzsch S. Feng R, et al. Among authors: lentzsch s. Br J Haematol. 2007 Nov;139(3):385-97. doi: 10.1111/j.1365-2141.2007.06772.x. Br J Haematol. 2007. PMID: 17910628 Free article.

4

KD5170, a novel mercaptoketone-based histone deacetylase inhibitor, exerts antimyeloma effects by DNA damage and mitochondrial signaling.

Feng R, Ma H, Hassig CA, Payne JE, Smith ND, Mapara MY, Hager JH, Lentzsch S. Feng R, et al. Among authors: lentzsch s. Mol Cancer Ther. 2008 Jun;7(6):1494-505. doi: 10.1158/1535-7163.MCT-08-0183. Mol Cancer Ther. 2008. PMID: 18566220

5

Sequential activation of inflammatory signaling pathways during graft-versus-host disease (GVHD): early role for STAT1 and STAT3.

Ma HH, Ziegler J, Li C, Sepulveda A, Bedeir A, Grandis J, Lentzsch S, Mapara MY. Ma HH, et al. Among authors: lentzsch s. Cell Immunol. 2011;268(1):37-46. doi: 10.1016/j.cellimm.2011.01.008. Epub 2011 Feb 4. Cell Immunol. 2011. PMID: 21376308 Free PMC article.

6

IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.

Li S, Pal R, Monaghan SA, Schafer P, Ouyang H, Mapara M, Galson DL, Lentzsch S. Li S, et al. Among authors: lentzsch s. Blood. 2011 May 12;117(19):5157-65. doi: 10.1182/blood-2010-10-314278. Epub 2011 Mar 9. Blood. 2011. PMID: 21389327 Free PMC article.

7

Targeting the microtubular network as a new antimyeloma strategy.

Feng R, Li S, Lu C, Andreas C, Stolz DB, Mapara MY, Lentzsch S. Feng R, et al. Among authors: lentzsch s. Mol Cancer Ther. 2011 Oct;10(10):1886-96. doi: 10.1158/1535-7163.MCT-11-0234. Epub 2011 Aug 8. Mol Cancer Ther. 2011. PMID: 21825007

8

Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study.

Lentzsch S, O'Sullivan A, Kennedy RC, Abbas M, Dai L, Pregja SL, Burt S, Boyiadzis M, Roodman GD, Mapara MY, Agha M, Waas J, Shuai Y, Normolle D, Zonder JA. Lentzsch S, et al. Blood. 2012 May 17;119(20):4608-13. doi: 10.1182/blood-2011-12-395715. Epub 2012 Mar 26. Blood. 2012. PMID: 22451423 Free PMC article. Clinical Trial.

9

Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.

Monaghan SA, Dai L, Mapara MY, Normolle DP, Gollin SM, Lentzsch S. Monaghan SA, et al. Among authors: lentzsch s. Leuk Lymphoma. 2013 Sep;54(9):1965-74. doi: 10.3109/10428194.2012.755177. Epub 2013 Jan 28. Leuk Lymphoma. 2013. PMID: 23216269 Free PMC article.

10

Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients.

Jurczyszyn A, Olszewska-Szopa M, Hungria V, Crusoe E, Pika T, Delforge M, Leleu X, Rasche L, Nooka AK, Druzd-Sitek A, Walewski J, Davila J, Caers J, Maisnar V, Gertz M, Gentile M, Fantl D, Mele G, Vesole DH, Yee AJ, Shustik C, Lentzsch S, Zweegman S, Gozzetti A, Skotnicki AB, Castillo JJ. Jurczyszyn A, et al. Among authors: lentzsch s. Leuk Lymphoma. 2016 Sep;57(9):2071-6. doi: 10.3109/10428194.2015.1128542. Epub 2016 Jan 4. Leuk Lymphoma. 2016. PMID: 26726867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters